메뉴 건너뛰기




Volumn 28, Issue 1, 2011, Pages 71-78

Randomized, double-blind, crossover study of palonosetron compared with granisetron for the prevention of chemotherapy-induced nausea and vomiting in a Chinese population

Author keywords

Chemotherapy induced nausea and vomiting; Granisetron; Palonosetron

Indexed keywords

ANTHRACYCLINE; CARBOPLATIN; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; GRANISETRON; OXALIPLATIN; PALONOSETRON;

EID: 79952252495     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9398-2     Document Type: Article
Times cited : (22)

References (17)
  • 2
    • 0031922859 scopus 로고    scopus 로고
    • Methodology of antiemetic trials: Response assessment, evaluation of new agents and definition of chemotherapy emetogenicity
    • DOI 10.1007/s005200050157
    • PJ Hesketh RJ Gralla AD Bois M Tonato 1998 Methodology of antiemetic trials: response assessment, evaluation of new agents and definition of chemotherapy emetogenicity Support Care Cancer 6 221 227 9629873 10.1007/s005200050157 1:STN:280:DyaK1c3ptFyhtw%3D%3D (Pubitemid 28213056)
    • (1998) Supportive Care in Cancer , vol.6 , Issue.3 , pp. 221-227
    • Hesketh, P.J.1    Gralla, R.J.2    Du Bois, A.3    Tonato, M.4
  • 4
    • 21044449000 scopus 로고    scopus 로고
    • ESMO minimum clinical recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV)
    • DOI 10.1093/annonc/mdi805
    • J Herrstedt MS Aapro F Roila VV Kataja 2005 ESMO minimum clinical recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV) Ann Oncol 16 Suppl 1 i77 i79 15888767 10.1093/annonc/mdi805 (Pubitemid 40872999)
    • (2005) Annals of Oncology , vol.16 , Issue.SUPPL. 1
    • Herrstedt, J.1    Aapro, M.S.2    Roila, F.3    Kataja, V.V.4
  • 5
    • 1342267601 scopus 로고    scopus 로고
    • Efficacy, safety and pharmacokinetics of palonosetron in patients receiving highly emetogenic cisplatin-based chemotherapy: A dose-ranging clinical study
    • DOI 10.1093/annonc/mdh047
    • P Eisenberg FR MacKintosh P Ritch PA Cornett A Macciocchi 2004 Efficacy, safety and pharmacokinetics of palonosetron in patients receiving highly emetogenic cisplatin-based chemotherapy: a dose-ranging clinical study Ann Oncol 15 330 337 14760130 10.1093/annonc/mdh047 1:STN:280:DC%2BD2c%2FlvValtw%3D%3D (Pubitemid 38262636)
    • (2004) Annals of Oncology , vol.15 , Issue.2 , pp. 330-337
    • Eisenberg, P.1    MacKintosh, F.R.2    Ritch, P.3    Cornett, P.A.4    Macciocchi, A.5
  • 6
    • 1942476106 scopus 로고    scopus 로고
    • Pharmacokinetic and Safety Evaluation of Palonosetron, a 5-Hydroxytryptamine-3 Receptor Antagonist, in U.S. and Japanese Healthy Subjects
    • DOI 10.1177/0091270004264641
    • R Stoltz JC Cyong A Shah S Parisi 2004 Pharmacokinetic and safety evaluation of palonosetron, a 5-hydroxytryptamine-3 receptor antagonist, in US and Japanese healthy subjects J Clin Pharmacol 44 520 531 15102873 10.1177/0091270004264641 1:CAS:528:DC%2BD2cXktlChtb0%3D (Pubitemid 38509721)
    • (2004) Journal of Clinical Pharmacology , vol.44 , Issue.5 , pp. 520-531
    • Stoltz, R.1    Cyong, J.-C.2    Shah, A.3    Parisi, S.4
  • 7
    • 10744219621 scopus 로고    scopus 로고
    • Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: Results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron
    • DOI 10.1093/annonc/mdg417
    • R Gralla, et al. 2003 Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron Ann Oncol 14 1570 1577 14504060 10.1093/annonc/mdg417 1:STN:280:DC%2BD3svktlKitQ%3D%3D (Pubitemid 37304615)
    • (2003) Annals of Oncology , vol.14 , Issue.10 , pp. 1570-1577
    • Gralla, R.1    Lichinitser, M.2    Van Der Vegt, S.3    Sleeboom, H.4    Mezger, J.5    Peschel, C.6    Tonini, G.7    Labianca, R.8    Macciocchi, A.9    Aapro, M.10
  • 8
    • 0344412945 scopus 로고    scopus 로고
    • 3 Receptor Antagonist: Results of a Phase III, Single-Dose Trial Versus Dolasetron
    • DOI 10.1002/cncr.11817
    • P Eisenberg, et al. 2003 Improved prevention of moderately emetogenic chemotherapy induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: results of a phase III, single-dose trial versus dolasetron Cancer 98 2473 2482 14635083 10.1002/cncr.11817 1:CAS:528:DC%2BD3sXpvFOrt70%3D (Pubitemid 37466663)
    • (2003) Cancer , vol.98 , Issue.11 , pp. 2473-2482
    • Eisenberg, P.1    Figueroa-Vadillo, J.2    Zamora, R.3    Charu, V.4    Hajdenberg, J.5    Cartmell, A.6    Macciocchi, A.7    Grunberg, S.8
  • 10
    • 58749100277 scopus 로고    scopus 로고
    • Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: A doubleblind, double-dummy, randomised, comparative phase III trial
    • 19135415 10.1016/S1470-2045(08)70313-9 1:CAS:528:DC%2BD1MXhtlGlurk%3D
    • M Saito, et al. 2009 Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a doubleblind, double-dummy, randomised, comparative phase III trial Lancet Oncol 10 115 124 19135415 10.1016/S1470-2045(08)70313-9 1:CAS:528:DC%2BD1MXhtlGlurk%3D
    • (2009) Lancet Oncol , vol.10 , pp. 115-124
    • Saito, M.1
  • 11
    • 57849152399 scopus 로고    scopus 로고
    • The efficacy and safety of palonosetron compared with granisetron in preventing highly emetogenic chemotherapy-induced vomiting in the Chinese cancer patients: A phase II, multicenter, randomized, double-blind, parallel, comparative clinical trial
    • 18825421 10.1007/s00520-008-0503-4
    • Z Yu, et al. 2009 The efficacy and safety of palonosetron compared with granisetron in preventing highly emetogenic chemotherapy-induced vomiting in the Chinese cancer patients: a phase II, multicenter, randomized, double-blind, parallel, comparative clinical trial Support Care Cancer 17 99 102 18825421 10.1007/s00520-008-0503-4
    • (2009) Support Care Cancer , vol.17 , pp. 99-102
    • Yu, Z.1
  • 13
    • 0032992455 scopus 로고    scopus 로고
    • Defining the emetogenicity of cancer chemotherapy regimens: Relevance to clinical practice
    • PJ Hesketh 1999 Defining the emetogenicity of cancer chemotherapy regimens: relevance to clinical practice Oncologist 4 191 196 10394587 1:STN:280:DyaK1Mzit1yqsw%3D%3D (Pubitemid 29297482)
    • (1999) Oncologist , vol.4 , Issue.3 , pp. 191-196
    • Hesketh, P.J.1
  • 14
    • 0028888664 scopus 로고
    • Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer. The Italian Group for Antiemetic Research
    • The Italian Group for Antiemetic Research. 10.1056/NEJM199501053320101
    • The Italian Group for Antiemetic Research 1995 Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer. The Italian Group for Antiemetic Research N Engl J Med 332 1 5 10.1056/NEJM199501053320101
    • (1995) N Engl J Med , vol.332 , pp. 1-5
  • 15
    • 0347816226 scopus 로고    scopus 로고
    • The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: A multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin - The Aprepitant Protocol 052 Study Group
    • DOI 10.1200/JCO.2003.01.095
    • PJ Hesketh, et al. 2003 The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, doubleblind, placebo-controlled trial in patients receiving high-dose cisplatin-the aprepitant protocol 052 study group J Clin Oncol 21 4112 4119 14559886 10.1200/JCO.2003.01.095 1:CAS:528:DC%2BD2cXpsVajtr0%3D (Pubitemid 46606178)
    • (2003) Journal of Clinical Oncology , vol.21 , Issue.22 , pp. 4112-4119
    • Hesketh, P.J.1    Grunberg, S.M.2    Gralla, R.J.3    Warr, D.G.4    Roila, F.5    De Wit, R.6    Chawla, S.P.7    Carides, A.D.8    Ianus, J.9    Elmer, M.E.10    Evans, J.K.11    Beck, K.12    Reines, S.13    Horgan, K.J.14
  • 16
    • 0029033527 scopus 로고
    • Comparative clinical trial of granisetron and ondansetron in the prophylaxis of cisplatin-induced emesis. The Granisetron study group
    • 7738628 1:STN:280:DyaK2M3ls12nuw%3D%3D
    • R Navari, et al. 1995 Comparative clinical trial of granisetron and ondansetron in the prophylaxis of cisplatin-induced emesis. The Granisetron study group J Clin Oncol 13 1242 1248 7738628 1:STN:280:DyaK2M3ls12nuw%3D%3D
    • (1995) J Clin Oncol , vol.13 , pp. 1242-1248
    • Navari, R.1
  • 17
    • 44849134443 scopus 로고    scopus 로고
    • Chemotherapy-induced nausea and vomiting
    • DOI 10.1056/NEJMra0706547
    • PJ Hesketh 2008 Chemotherapy-induced nausea and vomiting N Engl J Med 358 2482 2494 18525044 10.1056/NEJMra0706547 1:CAS:528:DC%2BD1cXmvFKltL0%3D (Pubitemid 351793021)
    • (2008) New England Journal of Medicine , vol.358 , Issue.23
    • Hesketh, P.J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.